Mobile coaching may help dialysis patients shed excess fluid

NCT ID NCT07677605

Not yet recruiting Disease control Sponsor: National Taipei University of Nursing and Health Sciences Source: ClinicalTrials.gov ↗

First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This trial tests a self-management program that uses education, WhatsApp reminders, and a diary to help hemodialysis patients control weight gain between sessions. The program aims to improve fluid adherence and stabilize blood pressure. Participants are adults on maintenance hemodialysis who own a smartphone and use WhatsApp.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Theory-based fluid self-management program
What this could lead to: If effective, this program could offer a simple, low-cost way for dialysis patients to better manage fluid intake and improve health outcomes.
What could go wrong: This is a behavioral intervention, not a drug, so results depend on patient engagement. The study is relatively small and may not apply to all dialysis patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for END-STAGE RENAL DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

end stage renal failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEMODIALYSIS PATIENT

Contacts and locations

Locations

Dr. Soeradji Tirtonegoro General Hospital l. Dr. Soeradji Tirtonegoro No.1, Dusun 1, Tegalyoso

Klaten, Central Java, 57424, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.